Recruiting studies: Patient Derived Organoid

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Patients Derived Organoids as a Promising Tool to Tailor Ovarian Cancer Therapies (PANDORA).
Phase N/A · 1 location(s) · Centro di Riferimento Oncologico - Aviano · NCT06229522 Organoid-based Functional Precision Therapy for Advanced Breast Cancer
Phase 2 · 1 location(s) · Guangdong Provincial People's Hospital · NCT06102824 Primary and Acquired Resistance to Targeted Treatment in BRAF V600E-mutated Metastatic Colorectal Cancer
Phase N/A · 13 location(s) · Swiss Cancer Institute · NCT07617610 Patient Derived Organoids (PDOs) to Observe the Clinical Consistency of Personalized Neoadjuvant Therapy for Resectable
Phase N/A · 1 location(s) · Shanghai Zhongshan Hospital · NCT07054086 Sensitivity of Organoids to Predict Treatment Outcome in Breast Cancer Metastases
Phase N/A · 2 location(s) · King's College London · NCT06468124 Drug Response Testing and Repurposing Using Glioblastoma Organoid
Phase N/A · 1 location(s) · Chungnam National University Hospital · NCT06782984 Patient-derived Organoids of Lung Cancer to Test Drug Response
Phase N/A · 1 location(s) · University Hospital, Geneva · NCT03979170 Pharmacotyping of Pancreatic Patient-derived Organoids
Phase N/A · 1 location(s) · Herlev Hospital · NCT05196334 Study to Investigate Outcome of Individualized Treatment in Patients With Metastatic Colorectal Cancer
Phase 2 · 1 location(s) · Oslo University Hospital · NCT05725200 Study to Determine the Antitumor Activity of New CAR-macrophages in Breast Cancer Patients' Derived Organoids
Phase N/A · 1 location(s) · Centre Oscar Lambret · NCT05007379 Patients Derived Organoids in Ovarian Cancer
NA · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT06085404 Modeling Ocular Developmental Diseases From 3D Cultures of Optic Vesicle Organoids Derived From hiPSCs of Patients With
Phase N/A · 2 location(s) · University Hospital, Toulouse · NCT06408701 Tumor Immune Microenvironment Involvement in Colorectal Cancer Chemoresistance Mechanisms
Phase N/A · 1 location(s) · University Hospital, Grenoble · NCT05038358 Efficacy of Personalized Tumorogram-based Therapy in Cancer Established From Patient-derived Organoid (AVATAR)
NA · 3 location(s) · Institut Curie · NCT06459791 PDO Based Drug Sensitive Test in R/M HNSCC
Phase N/A · 2 location(s) · Huashan Hospital · NCT06686342 Patient Derived Organoid-guided Personalized Treatment Versus Treatment of Physician's Choice in Breast Cancer
Phase 3 · 1 location(s) · Sun Yat-sen University · NCT06268652 A Living Tissue Bank of Patient-Derived Organoids From Glioma Tumors
Phase N/A · 1 location(s) · Maastricht Radiation Oncology · NCT04865315 Lab Research Using Mini-tumors to Study Prostate Cancer Treatments
Phase N/A · 3 location(s) · Maastricht Radiation Oncology · NCT07004582 Patient-derived Organoid Model and Circulating Tumor Cells for Treatment Response of Lung Cancer
Phase N/A · 1 location(s) · The University of Texas Health Science Center at San Antonio · NCT03655015 Characterization of Biliary Cell-derived Organoids From Bile of PSC and Non-PSC Patients
Phase N/A · 1 location(s) · Mayo Clinic · NCT04753996 PDO Based Drug Sensitive Test in R/M SGC
Phase N/A · 2 location(s) · Huashan Hospital · NCT06686979 Organoids From Breast Cancer Patients Treated With Neoadjuvant Therapy
Phase N/A · 1 location(s) · Istituti Clinici Scientifici Maugeri SpA · NCT07260188 Evaluation of ex Vivo Drug Combination Optimization Platform in Recurrent High Grade Astrocytic Glioma
NA · 2 location(s) · National University Hospital, Singapore · NCT05532397 Evaluation of Programmed Death Ligand 1 (PDL1) Response to Treatment in Extracellular Vesicles (EVs), Patient-derived Or
Phase 1/Phase 2 · 1 location(s) · GlaxoSmithKline · NCT06405230 Patient-Derived Organoid-on-a-Chip Model for Personalized Prediction of Chemotherapy Efficacy in Pancreatic Cancer
Phase N/A · 1 location(s) · Beijing Daxiang Biotech Co., Ltd · NCT07683845 Prospective Clinical Validation of Next Generation Sequencing (NGS) and Patient-Derived Tumor Organoids (PDO) Guided The
NA · 1 location(s) · Chinese University of Hong Kong · NCT06077591 Tailoring Treatment in Colorectal Cancer
Phase N/A · 1 location(s) · University Hospital, Akershus · NCT05401318 Organoid-guided Personalized Treatment of Pleural Effusion
Phase N/A · 1 location(s) · Henan Cancer Hospital · NCT06959173

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.